Fisetin 500mg | Mayo-Ranked Senolytic Flavonoid for Cellular Cleanup

The 30-second answer

Fisetin is a plant flavonoid — the most concentrated dietary source is the strawberry — that has emerged as one of the most-studied senolytics in human longevity research. A senolytic is a compound that selectively pushes senescent cells (the inflammation-leaking “zombie cells” that accumulate with age and refuse to die on their own) into apoptosis, while leaving healthy cells alone. In a Mayo Clinic head-to-head screen of ten natural flavonoids, fisetin was the most potent senolytic of the set (Yousefzadeh et al., EBioMedicine, 2018). That paper sparked a string of human clinical trials that are still running — the AFFIRM-LITE trial at Mayo (NCT03675724), the Wake Forest fisetin-osteoarthritis trial (NCT04210986), the kidney-disease pilot (NCT03325322), and several others mapped at ClinicalTrials.gov.

Each True Health Protocol bottle contains 60 vegan capsules, each providing 500 mg of fisetin standardized to 98% by HPLC from Rhus succedanea bark (the most concentrated natural source) plus 5 mg of BioPerine®-grade piperine to slow first-pass hepatic metabolism and lift plasma fisetin. Two protocols are supported by the literature: 500 mg daily (the “low-and-steady” longevity-community protocol) or 1,000 mg on two consecutive days each month (the “hit-and-run” pulse used in Mayo’s clinical trials). Both pair cleanly with NMN, Resveratrol, Spermidine, Apigenin, Quercetin, and CoQ10 because fisetin operates on a different longevity pathway than any of those: it removes damaged cells rather than tuning the metabolism of healthy ones.

What senescent cells are, and why clearing them matters

Every time one of your cells divides, it accumulates a small amount of damage — oxidized DNA bases, misfolded proteins, frayed telomeres. Most damaged cells either repair themselves or die cleanly through apoptosis, the orderly self-destruct that keeps tissue healthy. A small fraction does neither. They stop dividing but stay alive, locked in a metabolic state called cellular senescence. They’re no longer functional — but they’re also no longer cleared.

The problem isn’t that they sit there quietly. They actively secrete a soup of inflammatory cytokines, chemokines, growth factors, and matrix-remodeling enzymes called the Senescence-Associated Secretory Phenotype, or SASP (Coppe et al., Annual Review of Pathology, 2010). That secretion ages the tissue around the senescent cell — it inflames neighboring cells, recruits immune cells that exhaust trying to clear it, and remodels the extracellular matrix in ways that look strikingly like fibrosis or chronic inflammation. By age 60, depending on the tissue, the body carries four to ten times more senescent cells than it did at 30 (Tuttle et al., Aging Cell, 2020).

The senescent-cell hypothesis of aging is straightforward: a meaningful fraction of what we call “aging” — the slow loss of skin elasticity, the stiffening of arteries, the rise in tissue inflammation, the fading of immune function, the loss of muscle quality — is downstream of accumulated senescent cells leaking SASP into otherwise healthy tissue. Selectively clearing those cells should, in principle, reverse part of that decline.

That hypothesis was first tested in genetically engineered mice by the Mayo Clinic group of Jan van Deursen and James Kirkland (Baker et al., Nature, 2011, and the follow-up in 2016). When senescent cells were continuously cleared throughout adulthood, median lifespan extended 25–35%, healthspan markers (frailty, glucose tolerance, hair density, kyphosis, exercise capacity) improved, and several age-related diseases were delayed. That landmark result drove a search for chemical senolytics — compounds that could replicate genetic senescent-cell clearance pharmacologically. Fisetin emerged from exactly that search.

Why fisetin specifically: the Mayo head-to-head ranking

In 2018, Yousefzadeh and colleagues at Mayo Clinic and the Scripps Research Institute published a screen of ten natural flavonoids for senolytic activity (EBioMedicine, 2018, vol. 36, pp. 18–28). They tested fisetin, quercetin, luteolin, rutin, myricetin, apigenin, kaempferol, naringenin, catechin, and curcumin against senescent human umbilical-vein endothelial cells (HUVECs), murine embryonic fibroblasts, and aged mouse tissue. Fisetin was the only flavonoid in the set that significantly killed senescent cells across every assay at concentrations the others couldn’t match. In aged C57BL/6 mice, oral fisetin reduced senescent-cell burden in fat, kidney, and liver and extended median and maximum lifespan by approximately 9–10%. The conclusion was that fisetin — not quercetin, not curcumin, not the rest of the field — was the most potent natural senolytic flavonoid then known.

That paper landed at the perfect time. Mayo had already opened the AFFIRM-LITE trial (NCT03675724) using 20 mg/kg/day of fisetin for two consecutive days, repeated monthly — the same hit-and-run protocol that worked in the mouse studies. For a 75 kg adult, that translates to roughly 1,500 mg per day for two days. Subsequent Mayo trials (kidney disease, frailty, COVID-19 long-tail, osteoarthritis) all use variations of the same pulse architecture.

The mechanism Yousefzadeh et al. characterized is multimodal — fisetin doesn’t just hit one anti-apoptotic node, which is part of why it’s effective:

• BCL-2/BCL-xL inhibition — senescent cells become addicted to anti-apoptotic survival proteins (the “senescent-cell anti-apoptotic pathways,” or SCAPs). Fisetin partially inhibits BCL-2 family members, lifting the survival brake selectively in senescent cells.
• PI3K/AKT/mTOR modulation — fisetin downregulates this survival axis in senescent cells, which removes another pillar holding them alive.
• NF-κB suppression — fisetin damps the master regulator of SASP transcription, reducing inflammatory secretion even before the senescent cells are cleared.
• SIRT1 activation — like resveratrol, fisetin appears to activate SIRT1, the longevity sirtuin that overlaps with the NMN/NAD⁺ pathway.
• Direct flavonoid antioxidant activity — fisetin chelates iron, scavenges peroxyl radicals, and supports glutathione recycling, providing background antioxidant cover.

Three of those mechanisms (BCL-2 inhibition, PI3K/AKT downregulation, NF-κB suppression) are the same nodes targeted by the prescription senolytic combination dasatinib + quercetin (D+Q) studied at Mayo by Kirkland’s group (Justice et al., EBioMedicine, 2019, in idiopathic pulmonary fibrosis; Hickson et al., EBioMedicine, 2019, in diabetic kidney disease). Fisetin is being studied as a natural-product alternative because it hits the same SCAP nodes without dasatinib’s tyrosine-kinase-inhibitor side effect profile.

The human clinical trials — what we have and what is still pending

As of 2026, fisetin is the most-studied natural senolytic in active human trials. The notable ones:

• AFFIRM-LITE (NCT03675724) — Mayo Clinic, frailty in older women. 20 mg/kg/day × 2 consecutive days, monthly. Results expected to read out in 2026–2027.
• Fisetin in Diabetic CKD (NCT03325322) — pilot in chronic-kidney-disease patients, same pulse protocol. The kidney is one of the tissues with the highest senescent-cell burden in aged mice.
• Fisetin in Osteoarthritis (NCT04210986) — Wake Forest. Senescent chondrocytes in joint cartilage are implicated in OA pathogenesis (Jeon et al., Nature Medicine, 2017).
• Fisetin in Long COVID (NCT04476953) — the senescent-cell-clearance hypothesis for post-acute-sequelae symptoms.
• Khan et al., 2023 (Cell Metabolism) — the first peer-reviewed human safety/PK study of high-dose oral fisetin, confirming the pulse protocol is tolerated.

What we will not tell you: that these trials have already proven fisetin extends human lifespan. They have not. Most are still recruiting or in mid-readout. What the human data does show, consistently, is that the pulse protocol is well-tolerated, that plasma fisetin reaches senolytic concentrations, and that biomarkers of senescent-cell burden (p16^INK4a, SASP cytokines like IL-6 and IL-8) drop measurably after dosing. The mechanism translates from mouse to human. The clinical-outcome question — does this make people live longer or healthier — is what the next decade will answer.

The bioavailability problem (and why piperine matters)

Fisetin’s biggest limitation as an oral supplement is poor bioavailability. Like most flavonoids, it’s extensively metabolized on first pass through the liver: it gets glucuronidated and sulfated within minutes of absorption, so a large fraction of an oral dose is converted to inactive conjugates before it ever reaches a senescent cell. Pharmacokinetic studies put oral fisetin’s absolute bioavailability in the single digits without absorption support (Touil et al., Cancer Chemother Pharmacol, 2011; Krishnakumar et al., Eur J Pharm Sci, 2015).

Three strategies are used in the field:

1. Pair with piperine. Black-pepper extract is a pan-inhibitor of CYP3A4, UGT (glucuronidation), and SULT (sulfation) at the dose typical of supplements (5–10 mg). Across multiple flavonoids and curcuminoids, piperine roughly doubles plasma AUC. We use BioPerine®-grade piperine at 5 mg per capsule for this reason.
2. Take with dietary fat. Fisetin is fat-soluble. Plasma concentration is materially higher when it’s ingested with a meal containing some fat — eggs, avocado, full-fat yogurt, olive oil all work. This is part of why we recommend taking the daily capsule with breakfast rather than on an empty stomach.
3. Use a liposomal or phytosome carrier. Some products encapsulate fisetin in phospholipid liposomes or galactosylated nanoparticles. These can lift bioavailability further, though they’re harder to standardize and the published RCT base for liposomal fisetin specifically is thinner than for plain fisetin + piperine. We use the studied combination.

Combining piperine with a fatty meal is the protocol used in most contemporary fisetin trials. It’s simple, it’s evidence-based, and it’s what we’ve built into the formulation.

Form comparison: what to look for in a fisetin supplement

Fisetin is sold in several forms with very different real-world potency. Here’s how they compare:

• 98% standardized fisetin from Rhus succedanea (this product). The wax-tree (also known as Japanese sumac) is the most concentrated natural source of fisetin. Bark extract is concentrated and standardized to 98% fisetin by HPLC, which is what nearly every fisetin clinical trial has used. Each 500 mg capsule actually delivers ~490 mg of fisetin.
• Standardized fisetin from Cotinus coggygria (smoke bush). A second botanical source, also concentrated. Comparable potency to Rhus succedanea at the same standardization. Fine choice if it’s what’s available.
• Strawberry-extract fisetin. Fisetin is the marker compound that made fresh strawberries famous in flavonoid research, but a fresh strawberry is only ~0.16 mg fisetin per gram. Even a concentrated strawberry extract rarely exceeds a few percent fisetin by weight. A “strawberry fisetin” supplement may deliver 5–50 mg of actual fisetin per capsule — a fraction of the senolytic dose. Read the standardization label, not just the front of the bottle.
• Generic flavonoid blends labeled “senolytic complex.” Often combine quercetin + fisetin + apigenin + curcumin at low doses. Fine as a foundational antioxidant blend, but not what the senolytic literature dosed.
• Liposomal / phytosome fisetin. Higher bioavailability per milligram, but more expensive and the published RCT base for the specific liposomal form is thinner. The dose math also gets confusing — some labels report “equivalent to” doses rather than actual fisetin content.

A simple rule: if the label doesn’t state the percentage standardization (e.g., “98% fisetin by HPLC”) and the actual fisetin content per capsule, you can’t replicate the clinical-trial dose with it.

Two protocols, both supported in the literature

The fisetin-dosing question that comes up most often: daily or pulse? Both have backing.

The daily protocol: 500 mg with breakfast. One capsule a day, taken with a meal that contains some fat. This is what most longevity-community readers actually run, because consistency tends to win in real life and because fisetin’s background flavonoid effects (NF-κB suppression, antioxidant cover, SIRT1 activation) plausibly accrue with daily dosing. There is no published head-to-head comparison telling us this is superior to pulse dosing for senolytic outcomes — but it’s well-tolerated, simple, and integrates cleanly into a daily stack alongside NMN, resveratrol, and CoQ10.

The monthly pulse protocol: 1,000 mg on two consecutive days each month. This is the protocol Mayo’s clinical trials use and what worked in the original mouse studies. The senolytic logic is “hit and run” — you don’t need a senolytic on board every day, because senescent cells re-accumulate slowly. A high pulse dose drives them into apoptosis; the body clears the apoptotic debris over the following days; you wait three to four weeks and repeat. Pick a fixed pair of days each month (the 1st and 2nd, or the first weekend of the month) so you don’t forget.

The hybrid most readers settle into: 500 mg daily for the background flavonoid and gentler senescent-cell pressure, plus a once-per-quarter 2×1,000 mg pulse for a deeper clearance cycle. There’s no published trial of this hybrid — it’s a synthesis a lot of the longevity-medicine field has converged on as a practical compromise.

Either way, take it with food. The high-pulse protocol is meaningful enough that we recommend running it on a weekend (or any day with no high-stakes work or driving) the first time, just to know how your body responds.

How fisetin fits the rest of your stack

Fisetin solves a very specific problem — the buildup of senescent cells — that no other longevity supplement directly addresses. That makes it complementary to, not competitive with, almost everything else in a longevity stack. Three architectures to think about:

Stack 1: The Cellular Cleanup pair (most popular). Fisetin + Spermidine. Spermidine induces autophagy, the recycling machinery inside healthy cells that clears worn-out organelles and protein aggregates. Fisetin triggers apoptosis in cells too damaged to recycle. They handle the two ends of cellular waste management: keep healthy cells running cleanly (spermidine), and remove the cells that are beyond saving (fisetin). Add Quercetin 500mg if you want a second senolytic with overlapping mechanisms (Mayo’s D+Q protocol uses quercetin), or Apigenin 50mg if you also want a CD38 inhibitor protecting NAD⁺.

Stack 2: The NAD⁺/Sirtuin / Senolytic stack. Fisetin + Pure NMN 500mg (or NMN 1000mg Double Strength) + Resveratrol 600mg. NMN raises NAD⁺, the metabolic currency that sirtuins (and DNA-repair enzymes like PARPs) require. Resveratrol activates SIRT1 directly. Fisetin clears senescent cells so NAD⁺ isn’t being burned by inflammation in the first place. Add TMG 1000mg as the methyl-donor partner for NMN, and CoQ10 400mg for mitochondrial-membrane support.

Stack 3: The full Cellular Longevity Protocol. Fisetin + Spermidine + Quercetin + NMN + Resveratrol + Apigenin + CoQ10 + Urolithin A. Each of these targets a different hallmark of aging (senescent-cell clearance, autophagy, NAD⁺, sirtuin activation, CD38 inhibition, mitochondrial-membrane health, mitophagy). They’re not redundant. The Longevity Stack Bundle covers the NMN + resveratrol foundation; this fisetin SKU slots in alongside it.

Who this is for — and who it’s not for

Fisetin is for you if:

• You’re over 40 and have already built the NMN/resveratrol/CoQ10 foundation; you’re ready for the senolytic layer of a longevity stack.
• You’ve read the senescent-cell hypothesis literature and want to act on it before the prescription senolytics (D+Q, navitoclax) become widely available.
• You want a flavonoid that overlaps with the diet (strawberries) but at a dose food can’t reach.
• You’re running a structured longevity protocol and want a once-monthly pulse you can put on the calendar.

Fisetin is NOT for you if:

• You’re pregnant or breastfeeding (no safety data, and senolytic activity is the last thing a developing fetus needs — growing tissue depends on transient senescence as a normal developmental signal).
• You’re on warfarin, apixaban, rivaroxaban, dabigatran, or other anticoagulants — flavonoids modestly affect platelet aggregation and CYP-pathway anticoagulant metabolism. Discuss with your prescriber before starting.
• You have surgery scheduled in the next two weeks — pause for the same reason.
• You’re on chemotherapy or in active cancer treatment — senolytics have complex interactions with chemo (some agents induce senescence as a tumor-control mechanism, and clearing those cells changes the math). Coordinate with your oncologist.
• You’re on tamoxifen, dasatinib, or any other BCR-ABL/SRC kinase inhibitor — possible additive pathway effects.
• You’re under 18 — no studies in pediatric populations, and growing tissue uses transient senescence in normal development.
• You’re looking for a same-day energy or focus lift — senolytics work over months, not minutes. Choose NAD⁺ 1000mg Pure Focus for that.

What to expect, and on what timeline

Senolytic effects are slow and quiet. Most people don’t feel fisetin the way they might feel a B-vitamin or caffeine. The benefit is structural — fewer SASP-leaking cells in your tissues, less background inflammation, better tissue maintenance over time. Realistic expectations:

• Weeks 1–2: No noticeable subjective change. Some readers report a mild reduction in joint stiffness or skin reactivity, particularly if they’ve been carrying chronic low-grade inflammation. Plasma fisetin and metabolites peak within hours of dosing.
• Weeks 2–4: If you’re running the daily protocol, this is the window where some readers notice quieter joints (the senescent-chondrocyte hypothesis of OA), better post-exercise recovery, or a gentler skin-inflammation response. Still subtle.
• Weeks 4–8: The compounding window. Tissue-level senescent-cell burden is dropping in animal studies on this timeline. Subjective markers — recovery, joint comfort, skin tone — are typically more apparent at this point.
• 3–6 months: The structural payoff. The Mayo trials measure outcomes (frailty index, walking speed, kidney function, OA pain) at 3, 6, and 12 months. This is the timescale on which senolytic protocols are designed to read out. Continue running the protocol; this is the window the literature is built around.
• 12+ months: Sustained protocol territory. The animal-model lifespan effects accrue over the back half of life; the human equivalent is years of consistent protocol, not weeks.

If you’re someone who tracks objective markers (hsCRP, IL-6, kidney function, HRV, grip strength), those are the metrics fisetin is designed to move — and they move on the months-to-quarters timescale, not the days-to-weeks one.

Directions

Daily protocol: Take 1 capsule (500 mg fisetin + 5 mg piperine) with breakfast, on a meal that contains some fat. This is the simplest protocol and the one we recommend for most readers.

Monthly pulse protocol (Mayo Clinic style): Take 2 capsules (1,000 mg fisetin) on two consecutive days each month, with a meal. Pick a fixed pair of days (the first of the month and the day after, or the first weekend) so you don’t forget. Some readers run a weekend pulse to leave themselves space if they feel a transient inflammatory shift as senescent cells are cleared.

Hybrid (community protocol): 500 mg daily for the steady flavonoid layer plus a quarterly 2×1,000 mg pulse for deeper clearance cycles.

Pair the dose with NMN, Resveratrol, Spermidine, Apigenin, Quercetin, and CoQ10 freely — none of them compete with fisetin pharmacokinetically. Avoid stacking with other supplements that strongly inhibit clotting (high-dose fish oil, ginkgo, garlic extract) on pulse-dose days unless your clinician has weighed in.

What’s in the bottle

• Fisetin (98% pure, from Rhus succedanea bark extract): 500 mg per capsule
• Piperine (BioPerine®-grade black-pepper extract): 5 mg per capsule, included for bioavailability
• Capsule shell: vegetable cellulose (HPMC) — suitable for vegan and vegetarian diets
• No proprietary blend. Every active is disclosed at full label-claim weight.
• Free of: gluten, soy, dairy, GMO ingredients, titanium dioxide, magnesium stearate, artificial colors, and added sweeteners
• Tested: third-party verified by an ISO 17025–accredited laboratory for identity (HPLC), potency, heavy metals (lead, cadmium, mercury, arsenic), residual solvents, pesticide residues, and microbial contamination
• Manufacturing: cGMP-certified facility, NSF-registered process
• 60 capsules per bottle: 60-day supply at the daily protocol, or 30 monthly pulse cycles

Quality, sourcing, and supply chain

The fisetin in this bottle is sourced from Rhus succedanea bark, the most concentrated natural source — the same source used in nearly every published fisetin clinical trial. Raw material is extracted with food-grade ethanol and water, dried, milled, and standardized to 98% fisetin by HPLC. The 98% standardization matters: lower-grade extracts (50–70% fisetin) are less expensive but require more capsule weight to deliver the same fisetin dose, and the “balance” in those extracts is uncharacterized plant material.

BioPerine® is a 95%-piperine standardized extract of Piper nigrum manufactured by Sabinsa — the form used in most flavonoid bioavailability research. We use BioPerine® specifically rather than generic black-pepper powder because the published bioavailability data is on the standardized extract, not the spice.

Every batch is third-party tested. Certificates of analysis are available on request. Capsules are filled, sealed, and bottled at a cGMP-certified, NSF-registered facility under the supervision of a qualified analytical chemist.

The bottle is amber HDPE with a tamper-evident seal and an oxygen-absorber sachet. Store at room temperature, out of direct sunlight. Best used within 24 months of the manufacture date stamped on the bottom.

Safety and interactions

Fisetin is generally well-tolerated at the doses used in published clinical work. The flagged interactions, in order of importance:

• Anticoagulants and antiplatelets. Warfarin, apixaban, rivaroxaban, dabigatran, clopidogrel, aspirin at antiplatelet doses. Flavonoids can additively affect platelet aggregation and CYP3A4-mediated drug metabolism. Discuss with your prescriber before starting and pause 7–14 days before any planned procedure.
• Active chemotherapy or immunotherapy. Senolytics interact with cancer therapy in complex, sometimes opposing ways. Coordinate timing with your oncologist.
• Tamoxifen, dasatinib, BCR-ABL/SRC kinase inhibitors. Possible additive pathway effects.
• Pregnancy and breastfeeding. Not recommended — no safety data, and developmental tissue uses transient senescence as a normal signaling pathway.
• Surgery. Pause 14 days before any planned procedure for the platelet-aggregation reason.
• Liver disease. Hepatic metabolism of fisetin is extensive; talk to your hepatologist before starting if you have moderate-to-severe liver impairment.
• GI sensitivity to piperine. Rare but possible — some readers find black-pepper extract irritating on an empty stomach. Always take with a meal.

Reported side effects in the published literature are minimal at the daily 500 mg dose. At the 1,000–1,500 mg pulse dose, transient mild GI symptoms (loose stool, mild abdominal discomfort) and short-lived fatigue have been reported in a minority of subjects, generally resolving within 24–48 hours.

FAQ

How long until I notice anything?

Honestly, the senolytic effect is slow and quiet. Most readers don’t feel fisetin the way they feel caffeine or a B-vitamin. Subjective shifts (joint comfort, recovery, skin reactivity) start to appear in the 4–8 week window for daily users. Structural senescent-cell-clearance benefits accrue on the 3–12 month timescale — that’s how the Mayo trials are designed. If you’re looking for a same-day lift, choose NAD⁺ 1000mg Pure Focus; fisetin is a slow-burn longevity lever.

Should I run the daily or the monthly pulse protocol?

Mayo Clinic’s clinical trials use the pulse protocol because that’s what worked in the original mouse studies and it’s easier to standardize for research. Daily dosing at 500 mg is also studied (smaller human trials and a long history of strawberry-flavonoid epidemiology) and is what most longevity-community readers actually run, because consistency wins in real life. There is no published head-to-head telling us one is clearly better. We err toward daily for most readers and recommend the pulse for someone running a structured protocol with a monthly calendar reminder. The hybrid — daily plus quarterly pulse — is the practical compromise the field has converged on.

Can I take fisetin with quercetin?

Yes. Mayo’s D+Q (dasatinib + quercetin) trials specifically pair quercetin with another senolytic node, and the fisetin-plus-quercetin combination has been studied in animal work because they hit overlapping but non-identical SCAP nodes. They don’t antagonize each other. Many longevity protocols rotate or combine them. If you want both, our Quercetin 500mg SKU is the matched-dose pairing.

Why is piperine included?

Fisetin’s main weakness is poor bioavailability — most of an oral dose is glucuronidated and sulfated in the liver before reaching circulation. Piperine partially inhibits the CYP and UGT pathways responsible, roughly doubling plasma fisetin AUC in pharmacokinetic studies. The 5 mg dose is well below any threshold for stomach irritation or pharmacologically meaningful drug interaction.

Does fisetin replace Spermidine in the Cellular Longevity stack?

No — they do different jobs. Spermidine induces autophagy, the recycling process inside healthy cells that clears damaged organelles and protein aggregates. Fisetin triggers apoptosis in cells that are too damaged to recycle and need to be removed. They complement each other. Spermidine 10mg keeps healthy cells running cleanly; fisetin clears the cells that are beyond saving.

Why Rhus succedanea and not strawberry extract?

The marker compound that made fresh strawberries famous in fisetin research is the same molecule that’s in Rhus succedanea, but the concentration is wildly different. A pound of fresh strawberries delivers 8–10 mg of fisetin. A 500 mg capsule of 98% Rhus succedanea extract delivers ~490 mg. Strawberry-extract fisetin supplements typically deliver 5–50 mg of actual fisetin per capsule, which is below the senolytic dose used in any published trial. The botanical source matters less than the actual fisetin content per capsule.

Will I feel a “senescent-cell die-off”?

Some readers report a transient mild fatigue or a light flu-like feeling for 12–24 hours after the first 1,000 mg pulse dose — possibly the immune system clearing apoptotic-cell debris. This is uncommon, mild, and self-limited. If it happens, scale back to 500 mg for the next pulse and work up.

Can I take fisetin with NMN, resveratrol, and CoQ10?

Yes — this is the canonical longevity stack. Fisetin operates on a different pathway (clearing damaged cells) than NMN (raising NAD⁺), resveratrol (activating SIRT1), or CoQ10 (mitochondrial-membrane electron transport). They’re complementary. The Longevity Stack Bundle handles the NMN + resveratrol foundation; this fisetin SKU is the senolytic layer.

Is fisetin safe long-term?

The published human trials run 6–12 months at the pulse protocol and report no safety concerns at that timescale. Fisetin is also a normal dietary flavonoid — humans have eaten it in small amounts for as long as we’ve eaten strawberries and onions. The supplemental dose pushes the range up dramatically, so “long-term” in the supplement sense isn’t the same as the dietary baseline. We’re comfortable saying multi-year daily use looks safe based on what’s currently published; we’re not comfortable making claims past what the data shows.

What about fisetin and cancer?

This is where senolytic research gets interesting and complicated. Some chemotherapy drugs induce senescence as a tumor-control mechanism, so clearing those senescent cells with a senolytic can theoretically work both for and against cancer outcomes. Fisetin itself has been studied as a candidate adjuvant in some preclinical models. If you have an active cancer diagnosis or are on chemotherapy, this decision belongs with your oncologist, not with this product page.

Can I open the capsule and mix the powder into a smoothie?

You can, but fisetin is bitter and the piperine adds a peppery note. Most readers prefer to swallow the capsule whole and use a fatty meal as the absorption vehicle. If you do open it, mix into a fat-containing smoothie (Greek yogurt, nut butter, avocado, MCT oil) so the fat-soluble fisetin actually absorbs.

Does fisetin work for skin?

Indirectly, plausibly, slowly. Senescent fibroblasts and keratinocytes are part of the dermal-aging picture (Wang et al., Aging Cell, 2017). Clearing them in animal models improves dermal collagen content and skin elasticity. Whether that translates to a measurable cosmetic effect in humans on the timescale most readers care about (weeks to a few months) is not established. If skin is your primary outcome, pair fisetin with Marine Collagen 5000mg, Liposomal Vitamin C, and Astaxanthin 12mg rather than relying on fisetin alone.

Does fisetin work for joints?

This is one of the better-supported senolytic indications. Senescent chondrocytes accumulate in osteoarthritic cartilage, and the Wake Forest fisetin-OA trial (NCT04210986) is testing exactly that hypothesis in humans. Animal models show fisetin improves joint function and reduces cartilage damage in OA models (Zheng et al., FASEB J, 2018). The published human trial readout will tell us how strong the effect is. For now, joint comfort is one of the more frequently reported subjective benefits among long-term users.

Vegan? Allergens?

Yes — fully vegan. The capsule is HPMC (vegetable cellulose), the fisetin is botanical (Rhus succedanea), and the piperine is botanical (Piper nigrum). Free of soy, gluten, dairy, egg, fish, shellfish, tree nuts, and peanuts. Manufactured in a facility that handles tree nuts — if you have a severe nut allergy, contact us for the latest cross-contamination statement before ordering.

Read more

• Why your “senescent-cell load” matters more than your age
• The longevity supplement stack we actually take
• True Health Protocols — full daily, weekly, and monthly cellular-longevity routines
• Longevity Essentials collection
• Foundational Health collection
• Antioxidants collection

Disclaimer

The references on this page point to published peer-reviewed research about the mechanisms studied for fisetin and senescent-cell biology. They are not endorsements of this product by the cited researchers, their institutions, or the National Library of Medicine. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare provider before starting any new supplement — particularly if you are pregnant, breastfeeding, taking prescription medications (especially anticoagulants, antiplatelets, chemotherapy, or kinase inhibitors), or have a planned medical procedure.